Debbie L Hay
Debbie L Hay
Department of Pharmacology & Toxicology, University of Otago and School of Biological Sciences
Verified email at otago.ac.nz
Title
Cited by
Cited by
Year
Oxyntomodulin inhibits food intake in the rat
CL Dakin, I Gunn, CJ Small, CMB Edwards, DL Hay, DM Smith, ...
Endocrinology 142 (10), 4244-4250, 2001
3292001
GPCR modulation by RAMPs
DL Hay, DR Poyner, PM Sexton
Pharmacology & therapeutics 109 (1-2), 173-197, 2006
2462006
The concise guide to pharmacology 2017/18: overview
SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ...
British journal of pharmacology 174, S1-S16, 2017
2342017
The concise guide to PHARMACOLOGY 2015/16: Overview
SPH Alexander, E Kelly, N Marrion, JA Peters, HE Benson, E Faccenda, ...
British journal of pharmacology 172 (24), 5729-5743, 2015
2132015
Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes
DL Hay, G Christopoulos, A Christopoulos, DR Poyner, PM Sexton
Molecular pharmacology 67 (5), 1655-1665, 2005
1692005
Amylin: pharmacology, physiology, and clinical potential
DL Hay, S Chen, TA Lutz, DG Parkes, JD Roth
Pharmacological reviews 67 (3), 564-600, 2015
1602015
The concise guide to PHARMACOLOGY 2013/14: overview
SPH Alexander, HE Benson, E Faccenda, AJ Pawson, JL Sharman, ...
British journal of pharmacology 170 (8), 1449-1458, 2013
1532013
The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British Journal of Pharmacology 176, S21-S141, 2019
1462019
CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22–52, CGRP8–37 and…
DL Hay, SG Howitt, AC Conner, M Schindler, DM Smith, DR Poyner
British journal of pharmacology 140 (3), 477-486, 2003
1442003
Regulation of signal transduction by calcitonin gene-related peptide receptors
CS Walker, AC Conner, DR Poyner, DL Hay
Trends in pharmacological sciences 31 (10), 476-483, 2010
1372010
The pharmacology of adrenomedullin 2/intermedin
Y Hong, DL Hay, R Quirion, DR Poyner
British journal of pharmacology 166 (1), 110-120, 2012
1122012
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25
DL Hay, ML Garelja, DR Poyner, CS Walker
British journal of pharmacology 175 (1), 3-17, 2018
1112018
Receptor activity-modifying proteins (RAMPs): new insights and roles
DL Hay, AA Pioszak
Annual review of pharmacology and toxicology 56, 2016
982016
Cryo-EM structure of the active, G s-protein complexed, human CGRP receptor
YL Liang, M Khoshouei, G Deganutti, A Glukhova, C Koole, TS Peat, ...
Nature 561 (7724), 492-497, 2018
962018
A second trigeminal CGRP receptor: function and expression of the AMY1 receptor
CS Walker, S Eftekhari, RL Bower, A Wilderman, PA Insel, L Edvinsson, ...
Annals of Clinical and Translational Neurology 2 (6), 595-608, 2015
952015
Amylin receptors: molecular composition and pharmacology
DL Hay, G Christopoulos, A Christopoulos, PM Sexton
Biochemical Society Transactions 32 (5), 865-867, 2004
952004
Interaction of calcitonin-gene-related peptide with its receptors
AC Conner, DL Hay, SG Howitt, K Kilk, Langel, M Wheatley, DM Smith, ...
Biochemical Society Transactions 30 (4), 451-455, 2002
932002
International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor
DL Hay, DR Poyner, R Quirion
Pharmacological reviews 60 (2), 143-145, 2008
922008
Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl] carbonyl] pentyl] amino]-1-[(3, 5-dibromo-4-hydroxyphenyl) methyl]-2-oxoethyl]-4-(1…
DL Hay, G Christopoulos, A Christopoulos, PM Sexton
Molecular pharmacology 70 (6), 1984-1991, 2006
902006
Adrenomedullin receptors: molecular identity and function
DL Hay, DM Smith
Peptides 22 (11), 1753-1763, 2001
902001
The system can't perform the operation now. Try again later.
Articles 1–20